For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Québec G1V4X7

0 studies enrolling now · 7 studies all time

What they study most

Axial Spondyloarthritis, Cardiovascular Disease, Diabetes Mellitus, Type 2, Muscular Atrophy, Plaque Psoriasis, Primary Hypertension, Psoriasis, Psoriasis, Arthritic, Skin Diseases, Skin Diseases, Papulosquamous

Studies at this site

• A Study of LY2623091 in Participants With High Blood Pressure — Completed
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis — Completed
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) — Completed
• A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis — Completed
• A Study of Ixekizumab in Participants With Active Psoriatic Arthritis — Completed
• A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement — Completed